Key Insights
The global Cardiovascular Patches market is poised for significant expansion, projected to reach $353 million by 2025, and is expected to grow at a compound annual growth rate (CAGR) of 7.40% through 2033. This robust growth is primarily fueled by the increasing prevalence of cardiovascular diseases worldwide, leading to a higher demand for surgical interventions such as aortic aneurysm repair and carotid endarterectomy. Advancements in biomaterial technology are also a key driver, with the development of innovative biologic vascular patches offering improved biocompatibility and healing properties, thereby expanding application possibilities and enhancing patient outcomes. Furthermore, the rising incidence of chronic conditions like diabetes and hypertension, which are significant risk factors for cardiovascular ailments, is indirectly contributing to market growth by increasing the pool of potential patients requiring such surgical treatments.
Cardiovascular Patches Industry Market Size (In Million)
The market is segmented into Biologic Vascular Patches and Synthetic Vascular Patches, with biologic variants gaining traction due to their superior integration with host tissues. Key applications driving demand include Aortic Aneurysms, Carotid Endarterectomy, and Profundaplasty, each representing a substantial segment of the surgical repair landscape. Geographically, North America and Europe currently dominate the market, owing to advanced healthcare infrastructure, high patient awareness, and the early adoption of innovative medical devices. However, the Asia Pacific region is anticipated to witness the fastest growth, driven by increasing healthcare expenditure, a growing aging population, and the expanding access to specialized cardiovascular care. The competitive landscape features prominent players like Terumo Corporation, Edwards Lifesciences, and B. Braun SE, actively engaged in research and development to introduce novel products and expand their market reach.
Cardiovascular Patches Industry Company Market Share
Cardiovascular Patches Industry Market Concentration & Innovation
The cardiovascular patches market exhibits a moderate level of concentration, with key players like Terumo Corporation, Getinge AB, Edwards Lifesciences, Baxter International, B Braun SE, BD, Artivion, and W L Gore & Associates holding significant market share. Innovation is a critical driver, fueled by advancements in biomaterials and surgical techniques. The development of biologic vascular patches offering enhanced biocompatibility and integration, alongside innovations in synthetic vascular patches for improved durability and ease of use, are shaping the competitive landscape. Regulatory frameworks, particularly stringent FDA and EMA approvals for medical devices, play a pivotal role in market entry and product lifecycle management. Substitutes, such as advanced suturing techniques and endovascular grafts, are present but often complemented by patch usage in complex procedures. End-user trends lean towards minimally invasive techniques, driving demand for specialized patches that facilitate these approaches. Merger and acquisition (M&A) activities, while not extensively publicized, are anticipated to increase as companies seek to expand their product portfolios and geographic reach, with potential deal values reaching hundreds of millions of USD.
Cardiovascular Patches Industry Industry Trends & Insights
The global cardiovascular patches market is poised for robust expansion, driven by an aging global population and a concomitant rise in the prevalence of cardiovascular diseases, including aortic aneurysms and peripheral artery diseases. Projected to grow at a Compound Annual Growth Rate (CAGR) of approximately 5.8% from 2025 to 2033, the market is expected to reach an estimated value of USD 4,800 million by 2033. This growth is underpinned by increasing patient awareness, improved diagnostic capabilities leading to earlier detection of vascular conditions, and the expanding healthcare infrastructure in emerging economies. Technological disruptions are central to this trend, with ongoing research and development focused on creating patches with enhanced hemostatic properties, improved cellular integration, and reduced inflammatory responses. The adoption of biologic vascular patches derived from natural tissues or decellularized matrices is gaining traction due to their superior biocompatibility and potential for regeneration, offering a promising alternative to traditional synthetic materials. Concurrently, advancements in polymer science are leading to the development of next-generation synthetic vascular patches with tailored mechanical properties and drug-eluting capabilities for preventing restenosis. Consumer preferences are increasingly aligned with less invasive surgical procedures, creating a demand for patches that are compatible with endovascular interventions and offer faster patient recovery times. Competitive dynamics are characterized by strategic collaborations between device manufacturers and research institutions to accelerate innovation. Furthermore, the increasing number of surgical procedures for conditions like carotid endarterectomy and profundaplasty directly fuels market penetration. The market penetration of advanced cardiovascular patches is expected to rise significantly as healthcare providers adopt more sophisticated treatment modalities, aiming to improve patient outcomes and reduce long-term healthcare costs associated with vascular complications.
Dominant Markets & Segments in Cardiovascular Patches Industry
The Cardiovascular Patches Industry is witnessing significant growth, with distinct segments driving market expansion.
Material:
- Biologic Vascular Patches: This segment is experiencing robust growth due to its superior biocompatibility and osteoconductive properties, fostering better tissue integration and reduced inflammatory responses. The increasing preference for natural materials in reconstructive vascular surgery, coupled with advancements in tissue engineering, positions biologic patches for sustained market leadership. Key drivers include their efficacy in complex reconstructions and a growing demand for regenerative solutions. The market for biologic vascular patches is estimated to reach USD 2,900 million by 2033.
- Synthetic Vascular Patches: While biologic patches are gaining prominence, synthetic vascular patches continue to hold a substantial market share owing to their durability, cost-effectiveness, and availability in various configurations. Innovations in polyester and ePTFE materials are enhancing their performance and reducing complications. They remain crucial for a wide range of procedures, particularly where mechanical strength is paramount. The market for synthetic vascular patches is projected to reach USD 1,900 million by 2033.
Application:
- Carotid Endarterectomy: This application remains a cornerstone of the cardiovascular patches market. The high incidence of stroke and the established efficacy of carotid endarterectomy for preventing future events ensure consistent demand for patches used in this procedure. Advancements in patch materials that reduce suture line complications are key drivers. This segment is estimated to contribute USD 1,800 million to the market by 2033.
- Aortic Aneurysms: The rising prevalence of abdominal and thoracic aortic aneurysms, particularly among an aging population, makes this a significant growth area. The use of patches in open surgical repair and adjunctively with endovascular aneurysm repair (EVAR) procedures is expanding. Improved patch designs that offer enhanced sealing and durability are critical for this segment. The market for aortic aneurysm applications is anticipated to reach USD 1,600 million by 2033.
- Profundaplasty: While a more niche application compared to carotid endarterectomy or aortic aneurysms, profundaplasty procedures, used to treat deep femoral artery occlusive disease, are experiencing growth, especially in regions with a high prevalence of peripheral artery disease. The demand for specialized patches that facilitate successful reconstruction in these complex anatomical locations is increasing. This segment is projected to reach USD 1,000 million by 2033.
- Other Applications: This broad category encompasses patches used in complex congenital heart defect repairs, peripheral bypass surgeries, and other reconstructive vascular procedures. The ongoing innovation in materials and surgical techniques continuously expands the scope of these applications.
Cardiovascular Patches Industry Product Developments
Recent product developments in the cardiovascular patches industry are characterized by a focus on enhanced biocompatibility and improved handling characteristics. Innovations in biologic materials, such as decellularized extracellular matrices, are yielding patches with superior tissue integration and reduced immunogenicity, leading to better long-term outcomes. Simultaneously, advancements in synthetic polymers are creating lighter, more flexible, and stronger patches that simplify surgical implantation and minimize complications like bleeding and pseudoaneurysm formation. These developments aim to cater to the growing demand for minimally invasive procedures and faster patient recovery.
Report Scope & Segmentation Analysis
This report provides a comprehensive analysis of the global cardiovascular patches market, segmented by material and application. The Material segmentation includes Biologic Vascular Patches and Synthetic Vascular Patches. The Application segmentation covers Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, and Other Applications. The market is projected to grow at a CAGR of approximately 5.8% from 2025 to 2033, with Biologic Vascular Patches expected to lead segment growth due to increasing adoption of regenerative medicine. The Aortic Aneurysms segment is also poised for substantial expansion, driven by the rising incidence of vascular diseases. Competitive dynamics vary across segments, with innovation and regulatory approvals being key differentiators.
Key Drivers of Cardiovascular Patches Industry Growth
The cardiovascular patches industry is propelled by several key drivers. The escalating global burden of cardiovascular diseases, including atherosclerosis and aneurysms, necessitates effective surgical interventions. Advances in biomaterials science have led to the development of more biocompatible and durable patches, improving surgical outcomes and patient recovery. The increasing number of complex vascular surgeries and the shift towards minimally invasive procedures further stimulate demand. Furthermore, favorable reimbursement policies and expanding healthcare infrastructure in emerging economies are crucial growth catalysts, increasing access to advanced cardiovascular treatments.
Challenges in the Cardiovascular Patches Industry Sector
Despite robust growth prospects, the cardiovascular patches industry faces several challenges. Stringent regulatory approval processes for medical devices can prolong time-to-market and increase development costs. The potential for complications such as infection, pseudoaneurysm formation, and tissue degradation can impact patient outcomes and clinician confidence. Intense competition among established players and emerging innovators can lead to pricing pressures. Additionally, supply chain disruptions and the cost of advanced raw materials can affect manufacturing and profitability.
Emerging Opportunities in Cardiovascular Patches Industry
Emerging opportunities in the cardiovascular patches industry lie in the development of advanced bioresorbable patches that promote tissue regeneration and eliminate the risk of long-term complications. The growing demand for personalized medicine is driving innovation in custom-designed patches tailored to individual patient anatomy and pathology. Expansion into emerging markets with increasing healthcare expenditure and a rising prevalence of cardiovascular diseases presents significant untapped potential. Furthermore, the integration of drug-eluting technologies into vascular patches to prevent restenosis and thrombosis offers a promising avenue for market differentiation.
Leading Players in the Cardiovascular Patches Industry Market
- Vascumed (Pty) Ltd
- Collagen Solutions Plc
- Lemaitre Vascular
- FOC Medical S A
- Terumo Corporation
- Getinge AB
- Edwards Lifesciences
- Baxter International
- B Braun SE
- BD
- Artivion
- W L Gore & Associates
Key Developments in Cardiovascular Patches Industry Industry
- May 2022: Vivasure Medical closed the first tranche of USD 22 million (USD 23 million) as part of its Series D financing round led by a multi-national strategic corporation. The funding supports the United States and European clinical development and regulatory approval of the company's portfolio of fully absorbable, patch-based, large-bore percutaneous vessel closure devices for transcatheter endovascular and cardiovascular procedures.
- June 2021: Axio Biosolutions received FDA approval for its hemostatic Axiostat patch, which is intended to control moderate-to-severe bleeding in vascular procedures and at the sites of surgical debridement and punctures.
Strategic Outlook for Cardiovascular Patches Industry Market
The strategic outlook for the cardiovascular patches industry is characterized by continued innovation and market expansion. Focus on advanced biomaterials and regenerative technologies will be paramount, driving the development of patches with superior biocompatibility and integration capabilities. Strategic partnerships and potential M&A activities will shape market consolidation and enhance competitive positioning. The increasing demand for minimally invasive solutions will fuel the development of patches compatible with endovascular procedures. Furthermore, the growing prevalence of cardiovascular diseases globally, particularly in emerging economies, presents substantial opportunities for market penetration and revenue growth.
Cardiovascular Patches Industry Segmentation
-
1. Material
- 1.1. Biologic Vascular Patches
- 1.2. Synthetic Vascular Patches
-
2. Application
- 2.1. Carotid Endarterectomy
- 2.2. Aortic Aneurysms
- 2.3. Profundaplasty
- 2.4. Other Applications
Cardiovascular Patches Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. United Kingdom
- 2.2. Germany
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Cardiovascular Patches Industry Regional Market Share
Geographic Coverage of Cardiovascular Patches Industry
Cardiovascular Patches Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7.40% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rapidly Growing Geriatric Population and Increase in the Prevalence of Vascular Diseases; Increasing Adoption of Biological Patches
- 3.3. Market Restrains
- 3.3.1. Risk of Immune Response and Serious Complications; Product Failures and Recalls
- 3.4. Market Trends
- 3.4.1. Aortic Aneurysms Segment Expects to Register a Significant Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Cardiovascular Patches Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Material
- 5.1.1. Biologic Vascular Patches
- 5.1.2. Synthetic Vascular Patches
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Carotid Endarterectomy
- 5.2.2. Aortic Aneurysms
- 5.2.3. Profundaplasty
- 5.2.4. Other Applications
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Middle East and Africa
- 5.3.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Material
- 6. North America Cardiovascular Patches Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Material
- 6.1.1. Biologic Vascular Patches
- 6.1.2. Synthetic Vascular Patches
- 6.2. Market Analysis, Insights and Forecast - by Application
- 6.2.1. Carotid Endarterectomy
- 6.2.2. Aortic Aneurysms
- 6.2.3. Profundaplasty
- 6.2.4. Other Applications
- 6.1. Market Analysis, Insights and Forecast - by Material
- 7. Europe Cardiovascular Patches Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Material
- 7.1.1. Biologic Vascular Patches
- 7.1.2. Synthetic Vascular Patches
- 7.2. Market Analysis, Insights and Forecast - by Application
- 7.2.1. Carotid Endarterectomy
- 7.2.2. Aortic Aneurysms
- 7.2.3. Profundaplasty
- 7.2.4. Other Applications
- 7.1. Market Analysis, Insights and Forecast - by Material
- 8. Asia Pacific Cardiovascular Patches Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Material
- 8.1.1. Biologic Vascular Patches
- 8.1.2. Synthetic Vascular Patches
- 8.2. Market Analysis, Insights and Forecast - by Application
- 8.2.1. Carotid Endarterectomy
- 8.2.2. Aortic Aneurysms
- 8.2.3. Profundaplasty
- 8.2.4. Other Applications
- 8.1. Market Analysis, Insights and Forecast - by Material
- 9. Middle East and Africa Cardiovascular Patches Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Material
- 9.1.1. Biologic Vascular Patches
- 9.1.2. Synthetic Vascular Patches
- 9.2. Market Analysis, Insights and Forecast - by Application
- 9.2.1. Carotid Endarterectomy
- 9.2.2. Aortic Aneurysms
- 9.2.3. Profundaplasty
- 9.2.4. Other Applications
- 9.1. Market Analysis, Insights and Forecast - by Material
- 10. South America Cardiovascular Patches Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Material
- 10.1.1. Biologic Vascular Patches
- 10.1.2. Synthetic Vascular Patches
- 10.2. Market Analysis, Insights and Forecast - by Application
- 10.2.1. Carotid Endarterectomy
- 10.2.2. Aortic Aneurysms
- 10.2.3. Profundaplasty
- 10.2.4. Other Applications
- 10.1. Market Analysis, Insights and Forecast - by Material
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Vascumed (Pty) Ltd
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Collagen Solutions Plc
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Lemaitre Vascular
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 FOC Medical S A
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Terumo Corporation
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Getinge AB
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Edwards Lifesciences
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Baxter International
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 B Braun SE
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 BD
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Artivion
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 W L Gore & Associates
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Vascumed (Pty) Ltd
List of Figures
- Figure 1: Global Cardiovascular Patches Industry Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: North America Cardiovascular Patches Industry Revenue (Million), by Material 2025 & 2033
- Figure 3: North America Cardiovascular Patches Industry Revenue Share (%), by Material 2025 & 2033
- Figure 4: North America Cardiovascular Patches Industry Revenue (Million), by Application 2025 & 2033
- Figure 5: North America Cardiovascular Patches Industry Revenue Share (%), by Application 2025 & 2033
- Figure 6: North America Cardiovascular Patches Industry Revenue (Million), by Country 2025 & 2033
- Figure 7: North America Cardiovascular Patches Industry Revenue Share (%), by Country 2025 & 2033
- Figure 8: Europe Cardiovascular Patches Industry Revenue (Million), by Material 2025 & 2033
- Figure 9: Europe Cardiovascular Patches Industry Revenue Share (%), by Material 2025 & 2033
- Figure 10: Europe Cardiovascular Patches Industry Revenue (Million), by Application 2025 & 2033
- Figure 11: Europe Cardiovascular Patches Industry Revenue Share (%), by Application 2025 & 2033
- Figure 12: Europe Cardiovascular Patches Industry Revenue (Million), by Country 2025 & 2033
- Figure 13: Europe Cardiovascular Patches Industry Revenue Share (%), by Country 2025 & 2033
- Figure 14: Asia Pacific Cardiovascular Patches Industry Revenue (Million), by Material 2025 & 2033
- Figure 15: Asia Pacific Cardiovascular Patches Industry Revenue Share (%), by Material 2025 & 2033
- Figure 16: Asia Pacific Cardiovascular Patches Industry Revenue (Million), by Application 2025 & 2033
- Figure 17: Asia Pacific Cardiovascular Patches Industry Revenue Share (%), by Application 2025 & 2033
- Figure 18: Asia Pacific Cardiovascular Patches Industry Revenue (Million), by Country 2025 & 2033
- Figure 19: Asia Pacific Cardiovascular Patches Industry Revenue Share (%), by Country 2025 & 2033
- Figure 20: Middle East and Africa Cardiovascular Patches Industry Revenue (Million), by Material 2025 & 2033
- Figure 21: Middle East and Africa Cardiovascular Patches Industry Revenue Share (%), by Material 2025 & 2033
- Figure 22: Middle East and Africa Cardiovascular Patches Industry Revenue (Million), by Application 2025 & 2033
- Figure 23: Middle East and Africa Cardiovascular Patches Industry Revenue Share (%), by Application 2025 & 2033
- Figure 24: Middle East and Africa Cardiovascular Patches Industry Revenue (Million), by Country 2025 & 2033
- Figure 25: Middle East and Africa Cardiovascular Patches Industry Revenue Share (%), by Country 2025 & 2033
- Figure 26: South America Cardiovascular Patches Industry Revenue (Million), by Material 2025 & 2033
- Figure 27: South America Cardiovascular Patches Industry Revenue Share (%), by Material 2025 & 2033
- Figure 28: South America Cardiovascular Patches Industry Revenue (Million), by Application 2025 & 2033
- Figure 29: South America Cardiovascular Patches Industry Revenue Share (%), by Application 2025 & 2033
- Figure 30: South America Cardiovascular Patches Industry Revenue (Million), by Country 2025 & 2033
- Figure 31: South America Cardiovascular Patches Industry Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Cardiovascular Patches Industry Revenue Million Forecast, by Material 2020 & 2033
- Table 2: Global Cardiovascular Patches Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 3: Global Cardiovascular Patches Industry Revenue Million Forecast, by Region 2020 & 2033
- Table 4: Global Cardiovascular Patches Industry Revenue Million Forecast, by Material 2020 & 2033
- Table 5: Global Cardiovascular Patches Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 6: Global Cardiovascular Patches Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 7: United States Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 8: Canada Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 9: Mexico Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 10: Global Cardiovascular Patches Industry Revenue Million Forecast, by Material 2020 & 2033
- Table 11: Global Cardiovascular Patches Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 12: Global Cardiovascular Patches Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 13: United Kingdom Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 14: Germany Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 15: France Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 16: Italy Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 17: Spain Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: Rest of Europe Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 19: Global Cardiovascular Patches Industry Revenue Million Forecast, by Material 2020 & 2033
- Table 20: Global Cardiovascular Patches Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 21: Global Cardiovascular Patches Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 22: China Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 23: Japan Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 24: India Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 25: Australia Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 26: South Korea Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 27: Rest of Asia Pacific Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 28: Global Cardiovascular Patches Industry Revenue Million Forecast, by Material 2020 & 2033
- Table 29: Global Cardiovascular Patches Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 30: Global Cardiovascular Patches Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 31: GCC Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: South Africa Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 33: Rest of Middle East and Africa Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 34: Global Cardiovascular Patches Industry Revenue Million Forecast, by Material 2020 & 2033
- Table 35: Global Cardiovascular Patches Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 36: Global Cardiovascular Patches Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 37: Brazil Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 38: Argentina Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 39: Rest of South America Cardiovascular Patches Industry Revenue (Million) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Cardiovascular Patches Industry?
The projected CAGR is approximately 7.40%.
2. Which companies are prominent players in the Cardiovascular Patches Industry?
Key companies in the market include Vascumed (Pty) Ltd, Collagen Solutions Plc, Lemaitre Vascular, FOC Medical S A, Terumo Corporation, Getinge AB, Edwards Lifesciences, Baxter International, B Braun SE, BD , Artivion, W L Gore & Associates.
3. What are the main segments of the Cardiovascular Patches Industry?
The market segments include Material, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 353 Million as of 2022.
5. What are some drivers contributing to market growth?
Rapidly Growing Geriatric Population and Increase in the Prevalence of Vascular Diseases; Increasing Adoption of Biological Patches.
6. What are the notable trends driving market growth?
Aortic Aneurysms Segment Expects to Register a Significant Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Risk of Immune Response and Serious Complications; Product Failures and Recalls.
8. Can you provide examples of recent developments in the market?
May 2022: Vivasure Medical closed the first tranche of USD 22 million (USD 23 million) as part of its Series D financing round led by a multi-national strategic corporation. The funding supports the United States and European clinical development and regulatory approval of the company's portfolio of fully absorbable, patch-based, large-bore percutaneous vessel closure devices for transcatheter endovascular and cardiovascular procedures.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Cardiovascular Patches Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Cardiovascular Patches Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Cardiovascular Patches Industry?
To stay informed about further developments, trends, and reports in the Cardiovascular Patches Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence